Related Experiment Video
Updated: Aug 21, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Clinical management of chronic Chagas cardiomyopathy
Manoel O C Rocha1, Antonio Luiz P Ribeiro, Mauro M Teixeira
1Departamento de Clinica Medica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Avenida Alfredo Balena, 190, Belo Horizonte, MG, Brazil.
Insights
Chagas disease, caused by Trypanosoma cruzi, affects millions globally. This review focuses on diagnosing and managing chagasic cardiopathy, emphasizing parasite persistence in pathogenesis.
Area of Science:
- Infectious Diseases
- Cardiology
- Parasitology
Background:
- Chagas disease, caused by the protozoan Trypanosoma cruzi, impacts over 15 million people worldwide.
- While new infections are declining due to control programs, a significant population harbors chronic infection, at risk for developing chagasic cardiopathy.
- Chagasic cardiopathy is a major cause of heart failure and arrhythmias in endemic regions.
Purpose of the Study:
- To discuss the clinical diagnosis and management of Chagas cardiopathy.
- To emphasize clinical staging and diagnostic tools for personalized treatment.
- To highlight the role of parasite persistence in disease pathogenesis.
Main Methods:
- Review of clinical diagnosis and management strategies for Chagas cardiopathy.
- Emphasis on clinical staging and utilization of diagnostic tests.
- Discussion on the relevance of specific antiparasitic treatment.
Main Results:
- Chagasic cardiopathy presents with heart failure and arrhythmias.
- Individualized treatment approaches are crucial for managing these syndromes.
- Parasite persistence is a key factor in the development of Chagasic cardiopathy.
Conclusions:
- Effective management of Chagas cardiopathy requires accurate diagnosis and staging.
- Personalized treatment strategies are essential for addressing heart failure and arrhythmias.
- Understanding the role of parasite persistence is vital for Chagas disease pathogenesis and treatment.
Abstract:
Chagas disease is caused by a protozoan parasite, Trypanosoma cruzi, and infects over 15 million people worldwide. New cases of the disease are now uncommon, mainly due to national control programs in Latin America. However, there is a large reservoir of chronically infected patients, many of whom will develop chagasic cardiopathy. Here, the clinical diagnosis and management of Chagas cardiopathy are discussed. Particular emphasis is placed on the clinical staging of patients and the use of various diagnostic tests that may be useful in individualizing treatment of the two most relevant clinical syndromes, ie. heart failure and arrhythmias. Finally, the relevance of specific treatment is discussed, stressing the important role of parasite persistence for disease pathogenesis.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management
American Trypanosomiasis

